
Two stocks in the biotech space had dramatic moves over the last two days. One in Trevena Inc (TRVN), which moved from about $0.60 to nearly $1.50 per share over the last two days. The stock was up due to news of a pathway to possible FDA approval for its flagship product. The other big mover is Oncocyte Corp (OCX), whose stock rose from the low $2 range to nearly $7 per share over the last couple of days. Here’s what’s been moving them.